Could a shorter radiation schedule improve cervical cancer treatment?

NCT ID NCT07343531

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a shorter course of radiation therapy combined with chemotherapy for cervical cancer. The goal is to see if this approach is safe and effective, potentially reducing treatment time and improving outcomes. The trial will enroll 30 adults with stage II or III cervical cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
radiation therapy (moderately hypo-fractionated external beam radiotherapy and high dose rate brachytherapy) with chemotherapy (cisplatin or carboplatin)
What this could lead to
If successful, this could offer a shorter, more effective treatment option for cervical cancer, potentially improving survival and reducing side effects.
What could go wrong
This is a small, early-phase study with only 30 participants. The shorter radiation schedule may increase side effects or not be as effective as standard treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer cervical carcinoma Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ainshams University

    RECRUITING

    Cairo, Cairo Governorate, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.